000			01893 a2200553 4500
005			20250515230121.0
264		0	_c20101025
008			201010s 0 0 eng d
022			_a1744-7658
024	7		_a10.1517/13543784.2010.499898 _2doi
040			_aNLM _beng _cNLM
100	1		_aSchenone, Silvia
245	0	0	_aNovel dual Src/Abl inhibitors for hematologic and solid malignancies. _h[electronic resource]
260			_bExpert opinion on investigational drugs _cAug 2010
300			_a931-45 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAniline Compounds _xmetabolism
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aBenzodioxoles _xmetabolism
650	0	4	_aCSK Tyrosine-Protein Kinase
650	0	4	_aClinical Trials as Topic
650	0	4	_aDasatinib
650	0	4	_aDogs
650	0	4	_aDrug Evaluation, Preclinical
650	0	4	_aFusion Proteins, bcr-abl _xantagonists & inhibitors
650	0	4	_aHematologic Neoplasms _xdrug therapy
650	0	4	_aHumans
650	0	4	_aMice
650	0	4	_aMice, Knockout
650	0	4	_aMice, Nude
650	0	4	_aMice, SCID
650	0	4	_aNeoplasms _xdrug therapy
650	0	4	_aNitriles _xmetabolism
650	0	4	_aProtein Kinase Inhibitors _xmetabolism
650	0	4	_aProtein-Tyrosine Kinases _xantagonists & inhibitors
650	0	4	_aPyrimidines _xmetabolism
650	0	4	_aQuinazolines _xmetabolism
650	0	4	_aQuinolines _xmetabolism
650	0	4	_aRats
650	0	4	_aThiazoles _xmetabolism
650	0	4	_aTriazines _xmetabolism
650	0	4	_asrc-Family Kinases
700	1		_aBrullo, Chiara
700	1		_aMusumeci, Francesca
700	1		_aBotta, Maurizio
773	0		_tExpert opinion on investigational drugs _gvol. 19 _gno. 8 _gp. 931-45
856	4	0	_uhttps://doi.org/10.1517/13543784.2010.499898 _zAvailable from publisher's website
999			_c19906289 _d19906289